| scholarly article | Q13442814 |
| P50 | author | Allen Steere | Q4731886 |
| Robert B Lochhead | Q59687192 | ||
| Klemen Strle | Q105912937 | ||
| P2093 | author name string | Sheila L Arvikar | |
| Nancy D Kim | |||
| John M Aversa | |||
| Minna J Kohler | |||
| P2860 | cites work | The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America | Q22242935 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| IL-10 inhibits miR-155 induction by toll-like receptors | Q24618242 | ||
| miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression | Q24648145 | ||
| Antagonistic Interplay between MicroRNA-155 and IL-10 during Lyme Carditis and Arthritis | Q27300844 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy | Q30519448 | ||
| Lysosomal β-glucuronidase regulates Lyme and rheumatoid arthritis severity | Q30560471 | ||
| MicroRNA-146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi | Q33812777 | ||
| Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis | Q33999834 | ||
| microRNA regulation of inflammatory responses | Q34245279 | ||
| Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease | Q34301091 | ||
| Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis | Q34412483 | ||
| miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway | Q34529305 | ||
| Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production | Q34646554 | ||
| MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis | Q35091092 | ||
| MicroRNA function in myeloid biology | Q35220370 | ||
| Elucidation of Lyme arthritis | Q35709662 | ||
| β-Glucuronidase, a Regulator of Lyme Arthritis Severity, Modulates Lysosomal Trafficking and MMP-9 Secretion in Response to Inflammatory Stimuli | Q35931523 | ||
| Roles for microRNAs in conferring robustness to biological processes | Q35955737 | ||
| Mature T cell responses are controlled by microRNA-142. | Q36040220 | ||
| DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways | Q36088485 | ||
| A Highly Expressed Human Protein, Apolipoprotein B-100, Serves as an Autoantigen in a Subgroup of Patients With Lyme Disease | Q36250228 | ||
| A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease | Q36504045 | ||
| Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis | Q36784433 | ||
| MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts | Q36835508 | ||
| microRNA-mediated regulation of innate immune response in rheumatic diseases | Q36903302 | ||
| In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance | Q37472002 | ||
| MicroRNAs, new effectors and regulators of NF-κB. | Q37995687 | ||
| miR-223: infection, inflammation and cancer | Q38114927 | ||
| Diagnosis and treatment of Lyme arthritis | Q38496896 | ||
| Deregulation and therapeutic potential of microRNAs in arthritic diseases | Q38677327 | ||
| Significant impact of miRNA-target gene networks on genetics of human complex traits | Q38687454 | ||
| The emerging role of miR-223 as novel potential diagnostic and therapeutic target for inflammatory disorders | Q38821172 | ||
| Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis | Q41102420 | ||
| Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? | Q41206012 | ||
| Endothelial cells and fibroblasts amplify the arthritogenic type I IFN response in murine Lyme disease and are major sources of chemokines in Borrelia burgdorferi-infected joint tissue | Q42108192 | ||
| Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis | Q42139219 | ||
| Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. | Q42245505 | ||
| miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation | Q42631760 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: Moving toward individualized treatment decision-making | Q57788679 | ||
| Treatment of lyme arthritis | Q59745819 | ||
| The clinical evolution of Lyme arthritis | Q69415294 | ||
| Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis | Q79370194 | ||
| Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis | Q80123695 | ||
| The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis | Q83676869 | ||
| Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223 | Q84311843 | ||
| P433 | issue | 5 | |
| P921 | main subject | Lyme disease | Q201989 |
| microRNA expression | Q60681249 | ||
| P304 | page(s) | 1100-1110 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | MicroRNA Expression Shows Inflammatory Dysregulation and Tumor-Like Proliferative Responses in Joints of Patients With Postinfectious Lyme Arthritis | |
| P478 | volume | 69 |
| Q92598688 | A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis |
| Q41499985 | Alginate oligosaccharide indirectly affects toll-like receptor signaling via the inhibition of microRNA-29b in aneurysm patients after endovascular aortic repair |
| Q90102145 | Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review |
| Q92823894 | Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis |
| Q104571073 | Host transcriptome response to Borrelia burgdorferi sensu lato |
| Q49832618 | Inhibition of miR-155 attenuates abdominal aortic aneurysm in mice by regulating macrophage-mediated inflammation. |
| Q90499689 | Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells |
| Q90249928 | Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease |
| Q58610324 | Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2 |
Search more.